Blood transfusion safety remains a critical concern for hospitals across Nigeria and the wider continent, yet many patients still assume that a simple blood group match is enough. Medical laboratory scientists told PT Health Watch that donated blood must undergo a suite of additional laboratory checks—crossmatching, screening for transfusion‑transmissible infections (TTIs) and compatibility testing—before it can be released for use. Without these steps, the risk of adverse reactions, hemolysis, or infection persists, endangering lives in both urban and rural settings. Understanding the limits of blood grouping for blood transfusion safety Blood grouping identifies the ABO and Rh(D) antigens on red cells, a vital first step in matching donor and recipient. However, the ABO system alone does not account for other clinically significant antigens such as Kell, Duffy, or Kidd, which can trigger severe hemolytic reactions if mismatched. In Nigeria, where the prevalence of rare phenotypes is higher in certain ethnic groups, reliance on ABO matching alone can be especially risky. Moreover, blood group testing does not reveal hidden antibodies that a recipient may have developed from previous transfusions, pregnancies, or infections. These alloantibodies can cause delayed hemolytic transfusion reactions, a leading cause of post‑transfusion morbidity in African hospitals. Crossmatching: the essential compatibility check Crossmatching involves mixing a sample of the recipient’s serum with donor red cells to detect any unexpected antibodies. Two main methods are used: the immediate spin (IS) crossmatch, which quickly screens for ABO incompatibility, and the antiglobulin (AHG) crossmatch, which detects clinically significant antibodies beyond ABO. In well‑resourced labs across South Africa and Kenya, the AHG crossmatch is standard practice, reducing the incidence of alloimmunisation. In many Nigerian and Ghanaian facilities, resource constraints still limit routine AHG crossmatching. Experts urge health ministries to prioritise funding for automated crossmatch platforms, which not only improve safety but also speed up the release of blood for emergencies. Screening for transfusion‑transmissible infections Beyond compatibility, every unit of donated blood must be screened for TTIs such as HIV, hepatitis B and C, syphilis, and malaria. The Premium Times report highlighted that laboratories are required to run nucleic acid testing (NAT) or serological assays before blood can be cleared. In 2025, the West African Blood Transfusion Services (WABTS) introduced a regional quality assurance programme, yet gaps remain in rural clinics where only rapid tests are available. False‑negative results can occur if outdated kits are used or if staff are not adequately trained. The World Health Organization (WHO) recommends that all African nations adopt a minimum of two independent testing methods for each TTI, a standard that many countries are still working towards achieving. Why comprehensive testing matters for patients Consider the case of a 32‑year‑old mother in Lagos who required an emergency caesarean section. She received a unit matched only by ABO type, but the blood was later found to contain anti‑Kell antibodies that caused a severe hemolytic reaction, leading to prolonged intensive care. Such incidents underscore the importance of thorough pre‑transfusion testing. In South Africa, a national audit in 2026 showed that hospitals employing full crossmatching and TTI screening had a 70% lower rate of transfusion‑related complications compared with facilities that relied solely on blood grouping. The data reinforce that safety is a cumulative process, not a single test. Challenges facing African blood services Several systemic issues hinder the implementation of comprehensive testing: Funding gaps: Many national blood services operate on limited budgets, affecting procurement of reagents and maintenance of equipment. Human resource constraints: Skilled laboratory technologists are in short supply, especially in remote regions of Tanzania, Ethiopia, and the DRC. Infrastructure deficits: Unreliable power supply can compromise the performance of automated analyzers, leading to reliance on manual methods. Regulatory oversight: Inconsistent enforcement of national guidelines results in variable testing standards across countries. Addressing these challenges requires coordinated action from ministries of health, donor agencies, and professional bodies such as the Nigerian Society of Blood Transfusion (NSBT) and the African Society for Blood Transfusion (AfSBT). Best practices for hospitals and clinics Healthcare facilities can adopt several pragmatic steps to enhance blood transfusion safety: Implement a standard operating procedure (SOP) that mandates both ABO/Rh typing and AHG crossmatching for all non‑emergency transfusions. Adopt dual‑testing strategies for TTIs, combining rapid tests with confirmatory ELISA or NAT where feasible. Invest in continuous professional development for laboratory staff, focusing on quality control and result interpretation. Establish a robust traceability system, linking each blood unit to donor records and test results, to facilitate rapid recall if needed. Engage in regional blood sharing networks to mitigate shortages while maintaining safety standards. These measures not only protect patients but also build public confidence in the blood supply, encouraging voluntary donations—a cornerstone of safe transfusion services. Policy outlook for 2027 and beyond Looking ahead, the African Union’s 2027 Health Strategy emphasises the harmonisation of blood safety protocols across member states. The strategy calls for a continent‑wide accreditation system, similar to the European Blood Alliance, to ensure that every laboratory meets minimum testing criteria. In Nigeria, the Federal Ministry of Health announced plans to allocate an additional ₦15 billion over the next two years for blood safety infrastructure, including the rollout of automated crossmatch devices in 15 tertiary hospitals. Ghana’s National Blood Service is piloting a mobile testing unit to reach remote communities, while Kenya’s Ministry of Health is integrating electronic blood bank management systems to improve data accuracy. These initiatives signal a shift from reactive to proactive blood safety management, aligning Africa with global best practices. FAQ Q: Is blood grouping enough to prevent transfusion reactions?A: No. While essential, blood grouping must be complemented by crossmatching and infection screening to ensure full compatibility and safety. Q: What are the most common transfusion‑transmissible infections in Africa?A: HIV, hepatitis B and C, syphilis, and malaria are the primary TTIs screened for in African blood banks. Q: How can patients advocate for safer transfusions?A: Patients can ask their clinicians whether crossmatching and TTI screening have been performed and can request documentation of the test results. Conclusion Blood transfusion safety in Nigeria and across Africa hinges on more than a simple blood group match. Comprehensive testing—including crossmatching and rigorous TTI screening—remains the gold standard for protecting patients. As governments and health agencies invest in better equipment, training, and policy frameworks, the continent moves closer to a future where every transfused unit is both compatible and safe. For the full story, see the original PT Health Watch report here. Related Reading Unity Colleges Staff Suspend Strike, Paving Way for 115 Schools to Reopen Mother Considers Freezing Daughter’s Eggs After Rare Early Puberty Case Related posts: How Early Care Can save premature babies in Nigeria NCDC Confirms 1,086 Lassa Fever Cases and 259 Deaths in 2026 Outbreak Nigeria Evacuates Ebola Patient to Switzerland via Air Ambulance WHO Clarifies: Nigeria Still Not Declared Ebola–free Post navigation Helium Health Google Grant Fuels AI Fight Against Maternal Deaths Tragic End to a Young Hostage’s Ordeal Highlights Nigeria’s Bandit Crisis
